RATIONAL DESIGN OF POTENT, BIOAVAILABLE NONPEPTIDE CYCLIC UREAS AS HIV PROTEASE INHIBITORS

被引:0
|
作者
ERICKSONVIITANEN, S
LAM, PYS
JADHAV, PK
EYERMANN, CJ
HODGE, CN
RU, Y
BACHELER, LT
MEEK, JL
OTTO, MJ
RAYNER, MM
WONG, YN
CHANG, CH
WEBER, PC
JACKSON, DA
SHARPE, TR
机构
[1] DUPONT MERCK PHARMACEUT CO,DEPT VIROL RES,WILMINGTON,DE 19880
[2] DUPONT MERCK PHARMACEUT CO,DEPT CHEM & PHYS SCI,WILMINGTON,DE 19880
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:167 / 167
页数:1
相关论文
共 50 条
  • [11] L735,524 - THE RATIONAL DESIGN OF A POTENT AND ORALLY BIOAVAILABLE HIV PROTEASE INHIBITOR
    DORSEY, BD
    LEVIN, RB
    MCDANIEL, SL
    VACCA, JP
    DARKE, PL
    ZUGAY, JA
    EMINI, EA
    SCHLEIF, WA
    QUINTERO, JC
    LIN, JH
    CHEN, IW
    OSTOVIC, D
    FITZGERALD, PMD
    HOLLOWAY, MK
    ANDERSON, PS
    HUFF, JR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 6 - MEDI
  • [12] NOVEL AZA-CYCLIC UREAS THAT ARE POTENT INHIBITORS OF HIV-1 PROTEASE .1.
    SHAM, HL
    ZHAO, C
    STEWART, KD
    BETEBENNER, DA
    LIN, SQ
    PARK, CH
    KONG, XP
    ROSENBROOK, W
    HERRIN, T
    MADIGAN, D
    VASAVANONDA, S
    SALDIVAR, A
    MARSH, KC
    MCDONALD, E
    WIDEBURG, NE
    ROBINS, T
    KEMPF, DJ
    PLATTNER, JJ
    NORBECK, DW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 7 - MEDI
  • [13] PROTEIN STRUCTURE-BASED DESIGN OF POTENT ORALLY BIOAVAILABLE, NONPEPTIDE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE
    REICH, SH
    MELNICK, M
    DAVIES, JF
    APPELT, K
    LEWIS, KK
    FUHRY, MA
    PINO, M
    TRIPPE, AJ
    NGUYEN, D
    DAWSON, H
    WU, BW
    MUSICK, L
    KOSA, M
    KAHIL, D
    WEBBER, S
    GEHLHAAR, DK
    ANDRADA, D
    SHETTY, B
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) : 3298 - 3302
  • [14] TETRAHYDRO-2-PYRIMINONES AS POTENT NONPEPTIDE HIV PROTEASE INHIBITORS
    DELUCCA, GV
    LAM, PYS
    CHANG, CH
    MEEK, J
    RAYNER, M
    ERICKSONVIITANEN, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 4 - MEDI
  • [15] Novel azacyclic ureas that are potent inhibitors of HIV-1 protease
    Sham, HL
    Zhao, C
    Marsh, KC
    Betebenner, DA
    Lin, SQ
    Rosenbrook, W
    Herrin, T
    Li, LP
    Madigan, D
    Vasavanonda, S
    Molla, A
    Saldivar, A
    McDonald, E
    Wideburg, NE
    Kempf, D
    Norbeck, DW
    Plattner, JJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 225 (02) : 436 - 440
  • [16] Design, synthesis and SAR of a series of nonpeptide inhibitors of HIV protease
    Hagen, SE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U3315 - U3316
  • [17] A PHARMACOKINETIC EVALUATION OF HIV PROTEASE INHIBITORS, CYCLIC UREAS, IN RATS AND DOGS
    WONG, YN
    BURCHAM, DL
    SAXTON, PL
    ERICKSONVIITANEN, S
    GRUBB, MF
    QUON, CY
    HUANG, SM
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1994, 15 (07) : 535 - 544
  • [18] Heteroarylmethyl carboxamidobenzyl substituted cyclic ureas as HIV protease inhibitors.
    Sherk, SR
    Selby, TP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 279 - MEDI
  • [19] New series of potent, orally bioavailable, non-peptidic cyclic sulfones as HIV-1 protease inhibitors
    Kim, CU
    McGee, LR
    Krawczyk, SH
    Harwood, E
    Harada, Y
    Swaminathan, S
    Bischofberger, N
    Chen, MS
    Cherrington, JM
    Xiong, SF
    Griffin, L
    Cundy, KC
    Lee, A
    Yu, B
    Gulnik, S
    Erickson, JW
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (18) : 3431 - 3434
  • [20] RATIONAL DRUG DESIGN - INHIBITORS OF RENIN AND HIV PROTEASE
    TURNER, SR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 204 : 126 - ORGN